Rights and permissions
About this article
Cite this article
Phase I study of irinotecan combo in NSCLC promising. Inpharma Wkly. 943, 8 (1994). https://doi.org/10.2165/00128413-199409430-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199409430-00016